Hospital Italiano

Capital Federal C1199ABB

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-small-cell Lung, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed